# 2026-04406: NRC Eyes SHINE's License Shift to Chrysalis Entity

2026-04406, SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Consideration of Approval of Transfer of License and Conforming Amendment, is a Federal Register notice from Nuclear Regulatory Commission published 2026-03-06, effective Submit comments by April 6, 2026. A request for a hearing must be filed by March 26, 2026. Any potential party as defined in section 2.4 of title 10 of the Code of Federal Regulations (10 CFR), who believes access to SUNSI is necessary to respond to this notice must follow the instructions in Section VI of the SUPPLEMENTARY INFORMATION section of this notice. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04406
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04406
- Title: SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Consideration of Approval of Transfer of License and Conforming Amendment
- Type: Notice
- Agencies: Nuclear Regulatory Commission
- Citation: 91 FR 11089
- Published: 2026-03-06
- Effective: Submit comments by April 6, 2026. A request for a hearing must be filed by March 26, 2026. Any potential party as defined in section 2.4 of title 10 of the Code of Federal Regulations (10 CFR), who believes access to SUNSI is necessary to respond to this notice must follow the instructions in Section VI of the SUPPLEMENTARY INFORMATION section of this notice.
- Comments close: 2026-04-06
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

NRC Eyes SHINE's License Shift to Chrysalis Entity

## Summary

SHINE Technologies wants to move its license for a medical isotope facility to a new company called SHINE Chrysalis, with a new parent company in charge. The Nuclear Regulatory Commission is reviewing this change and asking the public to share their thoughts or request a hearing by late March or early April 2026. This switch won’t affect the facility’s operations or costs but updates who officially holds the license.

## Abstract

The U.S. Nuclear Regulatory Commission (NRC, the Commission) received and is considering approval of an application filed by Illuminated Holdings, Inc. and its wholly owned subsidiary, SHINE Technologies, LLC, on February 4, 2026. The application seeks NRC approval of the direct transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility, currently held by SHINE Technologies, LLC (the current licensee) to a newly formed company, SHINE Chrysalis, LLC, and issuance of a conforming license amendment. The application also seeks NRC approval of the indirect transfer of control of the construction permit as a result of the establishment of a new intermediate parent company, SHINE Chrysalis Holdings, LLC, which will be the direct corporate parent of SHINE Chrysalis, LLC. SHINE Chrysalis Holdings, LLC is a direct subsidiary of Illuminated Holdings, Inc. The application contains sensitive unclassified non-safeguards information (SUNSI).

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-19568](https://policyrisk.com/federal-register/2026-19568): Regulatory Enhancements for Reactor Licensing, Decommissioning, and Operational Oversight, 2026-09-24
- [2026-14341](https://policyrisk.com/federal-register/2026-14341): Modernizing Reactor Licensing, Safety Oversight, and Siting Practices, 2026-07-16
- [2026-13687](https://policyrisk.com/federal-register/2026-13687): Implementation of the National Environmental Policy Act, 2026-07-07
- [2026-12067](https://policyrisk.com/federal-register/2026-12067): Fee Schedules; Fee Recovery for Fiscal Year 2026, 2026-06-16
- [2026-08550](https://policyrisk.com/federal-register/2026-08550): Licensing Requirements for Microreactors and Other Reactors With Comparable Risk Profiles, 2026-05-01
- [2026-08015](https://policyrisk.com/federal-register/2026-08015): Generic Environmental Impact Statement for Licensing of New Nuclear Reactors, 2026-04-24

## Sources
- [2026-04406 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/06/2026-04406/shine-technologies-llc-shine-medical-isotope-production-facility-consideration-of-approval-of)
- [2026-04406 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-06/pdf/2026-04406.pdf)

## Related
- [Previous: 2026-04405, Certain Cold-Rolled Steel Flat Products From the Republic of Korea: Preliminary…](https://policyrisk.com/federal-register/2026-04405)
- [Next: 2026-04408, Agency Information Collection Activities; Submission for OMB Review; Comment Re…](https://policyrisk.com/federal-register/2026-04408)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04406 (as of 2026-06-08).
